Entrepreneurs lay more than €300 million on table for medical research

Saturday, 15 December 2018 10:01
Urbain Vandeurzen Urbain Vandeurzen © Made in Limburg
Urbain Vandeurzen, one of Belgium’s leading business entrepreneurs, has committed to spending €200 million through one of his companies to pay for research into Alzheimer’s disease.
Vandeurzen was a member of the board of the Flemish government’s investent arm GIMV for 12 years, and chairman for five. He has also sat on the board of Barco, Van Breda and the university of Leuven (KU Leuven), his alma mater where he gained a doctorate in engineering.

The money will go to researchers through his Mission Lucidity project, which will finance the KU Leuven, Leuven university hospital, the Flemish Institute for Biotechnology and Imec, the spin-off for computer chip research.

“Brain diseases are particularly complex, which makes it essential for us to pool our expertise,” he told De Tijd newspaper. “Until now, in Belgium we were mainly focussed on research at the universities. But we also have to involve doctors and engineers, in order to discover the origins of dementia and make real breakthroughs.”

One of those breakthroughs, it is hoped, will be the development of wearables – computers worn by patients to examine the processes involved in diseases such as Alzheimer’s, Parkinson’s and ALS or motor neuron disease, the condition suffered by the late Professor Stephen Hawking.

Vandeurzen is just the latest Flemish entrepreneur to invest heavily in medical research. Recently a group of about 20 captains of industry including Marc Coucke – creator of Omega Pharma and chairman of Anderlecht football club – and Christian Van Thillo, CEO of De Persgroep, which owns De Morgen as well as radio and TV stations, created a fund of €100 million to finance medical research into cancer treatments.

The Droia investment fund aims to attract another €50 million from outside investors for the research. Droia manager Janwillem Naesens told De Tijd: “The domain of oncology is now in a phase where mysteries are being solved. The latest treatments for leukemia, for example, mean that 90% of patients go into remission. True, many cancers are still not treatable, or only with difficulty. But we keep on making progress, cancer by cancer.”

Alan Hope
The Brussels Times
Google Plus

More Stories

About 100 children given up for adoption in Wallonia-Brussels in 2018

About 100 children given up for adoption in Wallonia-Brussels in 2018

In 2018, 96 children were given up for adoption in the Wallonia-Brussels Federation, Belga news agency reported on Friday, quoting figures from the Office of Minister of Youth Rachid Madrane.

Brussels Climate marchers move on to Paris

Brussels Climate marchers move on to Paris

Some 200 young people, including Swedish climate activist Greta Thunberg and her Belgian counterparts, Adelaïde Charlier, Kyra Gantois and Anuna de Wever, participated on Friday in Paris in the second day of a French youth-for-climate rally.

UK passport holders encouraged to check passport validity for post Brexit travel

UK passport holders encouraged to check passport validity for post Brexit travel

The UK government has developed a passport checker to allow British passport holders to see if they have enough time left on their passport before they travel to specific countries.